UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 196

Sortiert nach

Transcranial Electromagnetic Wave Treatment: A Fountain of Healthy Longevity?

International journal of molecular sciences, 2023-06, Vol.24 (11), p.9652

2023

Link zum Volltext

Verfügbarkeit prüfen

Caffeine and coffee as therapeutics against Alzheimer's disease

Journal of Alzheimer's disease, 2010-01, Vol.20 Suppl 1, p.S117

2010

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 Vaccines: Current Conditions and Future Prospects

Biology (Basel, Switzerland), 2021-09, Vol.10 (10), p.960

2021

Link zum Volltext

Verfügbarkeit prüfen

The Immune System as a Therapeutic Target for Alzheimer’s Disease

Life (Basel, Switzerland), 2022-09, Vol.12 (9), p.1440

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction: Cell Therapy: A Safe and Efficacious Therapeutic Treatment for Alzheimer's Disease in APP+PS1 Mice

PloS one, 2024-05, Vol.19 (5), p.e0303619-e0303619

2024

Link zum Volltext

Verfügbarkeit prüfen

The Multifaceted Role of Neuroprotective Plants in Alzheimer's Disease Treatment

Geriatrics (Basel), 2022-02, Vol.7 (2), p.24

2022

Link zum Volltext

Verfügbarkeit prüfen

Short, Lipidated Dendrimeric γ-AApeptides as New Antimicrobial Peptidomimetics

International journal of molecular sciences, 2023-03, Vol.24 (7), p.6407

2023

Link zum Volltext

Verfügbarkeit prüfen

Anti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease

PloS one, 2015-02, Vol.10 (2), p.e0116841-e0116841

2015

Link zum Volltext

Verfügbarkeit prüfen

Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction

Journal of Alzheimer's disease, 2011-01, Vol.26 (3), p.507

2011

Link zum Volltext

Verfügbarkeit prüfen

Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease

Journal of pineal research, 2009-08, Vol.47 (1), p.82-96

2009

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice

International journal of molecular sciences, 2022-03, Vol.23 (5), p.2757

2022

Link zum Volltext

Verfügbarkeit prüfen

Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson's Disease

International journal of molecular sciences, 2019-05, Vol.20 (9), p.2338

2019

Link zum Volltext

Verfügbarkeit prüfen

Acupuncture-Induced Analgesia: The Role of Microglial Inhibition

Cell Transplantation, 2016-04, Vol.25 (4), p.621-628

2016

Link zum Volltext

Verfügbarkeit prüfen

The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC

International journal of molecular sciences, 2022-04, Vol.23 (8), p.4253

2022

Link zum Volltext

Verfügbarkeit prüfen

Antioxidant Nutraceuticals: Preventive and Healthcare Applications

1, 2018

Link zum Volltext

Verfügbarkeit prüfen

Herb-drug interactions and mechanistic and clinical considerations

Current drug metabolism, 2012-06, Vol.13 (5), p.640

2012

Link zum Volltext

Verfügbarkeit prüfen

Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's disease mice

Journal of Alzheimer's disease, 2010-01, Vol.19 (1), p.191

2010

Link zum Volltext

Verfügbarkeit prüfen

Transcranial Electromagnetic Treatment "Rebalances" Blood and Brain Cytokine Levels in Alzheimer's Patients: A New Mechanism for Reversal of Their Cognitive Impairment

Frontiers in aging neuroscience, 2022-05, Vol.14, p.829049-829049

2022

Link zum Volltext

Verfügbarkeit prüfen

Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells

Neuropharmacology, 2012-12, Vol.63 (8), p.1368-1379

2012

Link zum Volltext

Verfügbarkeit prüfen

Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models

Viruses, 2022-02, Vol.14 (3), p.449

2022

Link zum Volltext

Verfügbarkeit prüfen

Transient Microneedle Insertion into Hippocampus Triggers Neurogenesis and Decreases Amyloid Burden in a Mouse Model of Alzheimer's Disease

Cell transplantation, 2016-10, Vol.25 (10), p.1853-1861

2016

Link zum Volltext

Verfügbarkeit prüfen

Aβ-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS

Neurobiology of disease, 2009-04, Vol.34 (1), p.63-70

2009

Link zum Volltext

Verfügbarkeit prüfen

High Blood caffeine levels in MCI linked to lack of progression to dementia

Journal of Alzheimer's disease, 2012-01, Vol.30 (3), p.559

2012

Link zum Volltext

Verfügbarkeit prüfen

Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders

Life (Basel, Switzerland), 2021-10, Vol.11 (11), p.1126

2021

Link zum Volltext

Verfügbarkeit prüfen

Behavior, protein, and dendritic changes after model traumatic brain injury and treatment with nanocoffee particles

BMC neuroscience, 2019-08, Vol.20 (1), p.44-10, Article 44

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 196

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(165)

Publikationsform

Sprache

Englisch
(195)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Transcranial Electromagnetic Wave Treatment: A Fountain of Healthy Longevity?

Caffeine and coffee as therapeutics against Alzheimer's disease

COVID-19 Vaccines: Current Conditions and Future Prospects

The Immune System as a Therapeutic Target for Alzheimer’s Disease

Correction: Cell Therapy: A Safe and Efficacious Therapeutic Treatment for Alzheimer's Disease in APP+PS1 Mice

The Multifaceted Role of Neuroprotective Plants in Alzheimer's Disease Treatment

Short, Lipidated Dendrimeric γ-AApeptides as New Antimicrobial Peptidomimetics

Anti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease

Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction

Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease

Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice

Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson's Disease

Acupuncture-Induced Analgesia: The Role of Microglial Inhibition

The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC

Antioxidant Nutraceuticals: Preventive and Healthcare Applications

Herb-drug interactions and mechanistic and clinical considerations

Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's disease mice

Transcranial Electromagnetic Treatment "Rebalances" Blood and Brain Cytokine Levels in Alzheimer's Patients: A New Mechanism for Reversal of Their Cognitive Impairment

Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells

Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models

Transient Microneedle Insertion into Hippocampus Triggers Neurogenesis and Decreases Amyloid Burden in a Mouse Model of Alzheimer's Disease

Aβ-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS

High Blood caffeine levels in MCI linked to lack of progression to dementia

Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders

Behavior, protein, and dendritic changes after model traumatic brain injury and treatment with nanocoffee particles

Suchergebnisse filtern